JP2023526980A5 - - Google Patents

Info

Publication number
JP2023526980A5
JP2023526980A5 JP2022571817A JP2022571817A JP2023526980A5 JP 2023526980 A5 JP2023526980 A5 JP 2023526980A5 JP 2022571817 A JP2022571817 A JP 2022571817A JP 2022571817 A JP2022571817 A JP 2022571817A JP 2023526980 A5 JP2023526980 A5 JP 2023526980A5
Authority
JP
Japan
Prior art keywords
dosage form
hydroxyvitamin
hard capsule
form according
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022571817A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023526980A (ja
Filing date
Publication date
Priority claimed from PCT/IB2021/000220 external-priority patent/WO2021205225A1/en
Application filed filed Critical
Priority claimed from PCT/IB2021/000376 external-priority patent/WO2021245458A1/en
Publication of JP2023526980A publication Critical patent/JP2023526980A/ja
Publication of JP2023526980A5 publication Critical patent/JP2023526980A5/ja
Pending legal-status Critical Current

Links

JP2022571817A 2020-05-31 2021-05-31 ハードカプセル剤形及びその使用 Pending JP2023526980A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063032714P 2020-05-31 2020-05-31
US63/032,714 2020-05-31
PCT/IB2021/000220 WO2021205225A1 (en) 2020-04-06 2021-04-06 25-hydroxyvitamin d for the treatment of sars-cov-2 infection
IBPCT/IB2021/000220 2021-04-06
PCT/IB2021/000376 WO2021245458A1 (en) 2020-05-31 2021-05-31 Hard capsule dosage form and uses thereof

Publications (2)

Publication Number Publication Date
JP2023526980A JP2023526980A (ja) 2023-06-26
JP2023526980A5 true JP2023526980A5 (enExample) 2024-06-06

Family

ID=78831505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022571817A Pending JP2023526980A (ja) 2020-05-31 2021-05-31 ハードカプセル剤形及びその使用

Country Status (9)

Country Link
US (2) US20230293552A1 (enExample)
EP (1) EP4157231A1 (enExample)
JP (1) JP2023526980A (enExample)
KR (1) KR20230017192A (enExample)
CN (2) CN115768412A (enExample)
AU (1) AU2021285494A1 (enExample)
CA (1) CA3181945A1 (enExample)
IL (1) IL297885A (enExample)
WO (1) WO2021245458A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021245458A1 (en) * 2020-05-31 2021-12-09 Eirgen Pharma Ltd. Hard capsule dosage form and uses thereof
WO2024063039A1 (ja) * 2022-09-20 2024-03-28 ロンザ株式会社 酸化マグネシウムを含有する遮光性ハードカプセル
WO2025094144A1 (en) 2023-11-02 2025-05-08 Eirgen Pharma Ltd. Controlling loss of kidney function

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264223A (en) 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5431917A (en) 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
FR2757173A1 (fr) 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
KR100379674B1 (ko) 2000-03-06 2003-04-10 주식회사 서흥캅셀 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법
CA2519208A1 (en) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited Controlled release composition
CA2882048C (en) 2006-02-03 2020-03-24 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
HUE037309T2 (hu) * 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
RU2420538C2 (ru) * 2006-10-27 2011-06-10 Пфайзер Продактс Инк. Жесткие капсулы из гидроксипропилметилцеллюлозы и способ их получения
ES2401205T3 (es) * 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
CA2683514C (en) * 2007-04-25 2019-07-09 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
PT2321273E (pt) * 2008-07-24 2014-12-29 Wisconsin Alumni Res Found Administração semanal de 25-hidroxi-vitamina d3 para manter concentração sanguínea elevada numa farmacocinética de estado estacionário
PL2480218T3 (pl) * 2009-09-24 2020-11-16 Capsugel Belgium Nv Kapsułki odporne na kwas
KR20140072715A (ko) * 2012-12-05 2014-06-13 삼성정밀화학 주식회사 경질 캡슐
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) * 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
EP4596045A3 (en) 2016-03-28 2025-10-15 EirGen Pharma Ltd. Methods of vitamin d treatment
US12214084B2 (en) * 2017-07-11 2025-02-04 Qualicaps Co., Ltd. Enteric hard capsule
WO2020044314A1 (en) 2018-08-31 2020-03-05 Opko Ireland Global Holdings, Ltd. Vitamin d pediatric dosage forms, methods of making and using
US20210308151A1 (en) * 2020-04-06 2021-10-07 Eirgen Pharma Ltd. Activating endogenous antimicrobials to treat sars-cov-2 infection
WO2021245458A1 (en) * 2020-05-31 2021-12-09 Eirgen Pharma Ltd. Hard capsule dosage form and uses thereof

Similar Documents

Publication Publication Date Title
EP1265617B1 (fr) Nouvelles compositions estro-progestatives topiques a effet systemique
DE3875705T2 (de) Carbidopa-levodopa-zusammensetzung mit gesteuerter freigabe.
JP4579411B2 (ja) 全身作用を有する局所ホルモン組成物
PT98291B (pt) Processo para a preparacao de composicoes farmaceuticas contendo flupirtina para combater distensoes musculares
US11304910B2 (en) Soft gelatin capsules with pH-independent release
JP2020193220A (ja) 医薬組成物および方法
EP1615632B1 (fr) Formulations orales flottantes pour la liberation controlee de la betaine
NL8203343A (nl) Farmaceutisch preparaat.
WO2017037647A1 (en) Stable pharmaceutical compositions of abiraterone
EP4157231A1 (en) Hard capsule dosage form and uses thereof
CA1216793A (en) Pge-type compositions encapsulated by acid isolated gelatin
JP2024513604A5 (enExample)
RU2010103934A (ru) Стабильная фармацевтическая композиция, содержащая водорастворимую соль винфлунина
WO2024086629A3 (en) Anhydrous oral pharmaceutical suspensions
WO2013083558A1 (en) Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
CN111936119B (zh) 甲状腺激素在软胶囊中的高度稳定制剂
JP2025504003A5 (enExample)
WO1992022305A1 (fr) Composition therapeutique pour liberation prolongee de magnesium
JP5852816B2 (ja) 液状医薬組成物、及びこれを含有する軟カプセル剤
CA3007592C (en) Soft gelatin capsules with ph-independent release
HK40107157A (zh) 甲状腺激素在软胶囊中的高度稳定制剂
CN112546004A (zh) 一种氟骨三醇片
WO2025017264A1 (fr) Nouvelle utilisation d'un extrait de la microalgue phaeodactylum tricornutum
CN118286175A (zh) 一种骨化三醇液体软胶囊剂及其制备方法
EP0066505A1 (fr) Préparation pharmaceutique de "naftidrofuryl" à libération contrôlée